SCHEDULE: D. E. Shaw Entities Reduce Gossamer Bio Stake

D. E. Shaw entities have collectively reduced their beneficial ownership in Gossamer Bio, Inc. to 6.0% through a series of sales between late July and late August 2026.

Summary

• D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., and David E. Shaw have filed an amendment to their Schedule 13D regarding their beneficial ownership of Gossamer Bio, Inc. common stock.
• As of August 8, 2026, Gossamer Bio, Inc. had 488,846,722 common shares outstanding.
• The reporting persons, through Valence and Cogence, collectively beneficially owned 29,128,194 common shares, representing 6.0% of the outstanding shares.
• Between July 27, 2026, and August 24, 2026, the reporting persons engaged in significant net selling of Gossamer Bio, Inc. common shares.
• The total number of shares sold during this period was 2,700,000, with purchases totaling 0.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the significant net selling of shares by the reporting persons, indicating a potential lack of confidence or a strategic shift away from the company.

Negatives

• The reporting persons have significantly reduced their stake in Gossamer Bio, Inc. through net sales totaling 2,700,000 shares between July 27, 2026, and August 24, 2026.
• No shares were purchased by the reporting persons during the period from July 27, 2026, to August 24, 2026.

Risks

• The substantial net selling of shares by significant beneficial owners like D. E. Shaw entities could signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment and share price.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Gossamer Bio, Inc. The information pertains to the beneficial ownership and trading activities of D. E. Shaw entities.

Industry Context

StockSavvy.ai notes that significant shifts in beneficial ownership by large investment firms, as indicated by this Schedule 13D amendment, can be a strong signal to the market. Such actions often precede or reflect changes in a company's valuation or strategic direction.

Stakeholder Impact

• Shareholders may view the significant selling by D. E. Shaw entities as a negative signal, potentially leading to downward pressure on the stock price.
• The reduction in ownership by a major investor could affect market perception and confidence in Gossamer Bio, Inc.

Next Steps

• The reporting persons will continue to monitor the business and financial condition of Gossamer Bio, Inc.
• Future transactions in the securities of Gossamer Bio, Inc. by the reporting persons will be disclosed as required by law.

Key Dates

Recommendation

The filing indicates a significant reduction in holdings by a major investor, which is a negative signal. However, without further context on the reasons for the sale or the company's underlying performance, a 'hold' recommendation is prudent, suggesting investors should monitor the situation before making further decisions.

Keywords

Gossamer Bio, Schedule 13D, Beneficial Ownership, D. E. Shaw, Common Stock, Securities Trading, Investment Management